Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Mazor

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|April 30, 2023
TRAF3 suppression encourages B cell recruitment and prolongs survival of microbiome-intact mice with ovarian cancerJonathan Zorea, Yair Motro, Roei D Mazor, et al.
Environmental Monitoring and Assessment|November 12, 2014
Correspondence of biological condition models of California streams at statewide and regional scalesJason T May, Larry R Brown, Andrew C Rehn, et al.
Water|November 2, 2020
Classifying Streamflow Duration: The Scientific Basis and an Operational Framework for Method DevelopmentKen M Fritz, Tracie-Lynn Nadeau, Julia E Kelso, et al.
Peerj|August 4, 2020
The importance of open science for biological assessment of aquatic environmentsMarcus W Beck, Casey O'Hara, Julia S Stewart Lowndes, et al.
The Journal of Experimental Medicine|September 24, 2017
ICAMs support B cell interactions with T follicular helper cells and promote clonal selectionIrina Zaretsky, Ofir Atrakchi, Roei D Mazor, et al.
Neuro-Oncology Advances|July 10, 2020
Dual BRAF/MEK blockade restores CNS responses in BRAF-mutant Erdheim-Chester disease patients following BRAF inhibitor monotherapyRoei D Mazor, Ran Weissman, Judith Luckman, et al.
Environmental Science. Processes & Impacts|June 15, 2017
High throughput in vitro and in vivo screening of inland waters of Southern CaliforniaA C Mehinto, D R VanDervort, W Lao, et al.
Transplantation and Cellular Therapy|April 9, 2025
Omidubicel-onlv Transplantation for Hematologic Malignancies: Results of a Multicenter Expanded Access ProgramMitchell E Horwitz, Gary J Schiller, Stephanie B Tsai, et al.
BMC Medicine|December 2, 2014
Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case seriesRoei D Mazor, Mirra Manevich-Mazor, Anat Kesler, et al.
Kidney International|November 14, 2022
Clinical phenotypes and long-term outcome of kidney involvement in Erdheim-Chester histiocytosisThibaud Chazal, Francesco Pegoraro, Gaia Manari, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Journal of Experimental & Clinical Cancer Research : CR|April 30, 2023
TRAF3 suppression encourages B cell recruitment and prolongs survival of microbiome-intact mice with ovarian cancerJonathan Zorea, Yair Motro, Roei D Mazor, et al.
Environmental Monitoring and Assessment|November 12, 2014
Correspondence of biological condition models of California streams at statewide and regional scalesJason T May, Larry R Brown, Andrew C Rehn, et al.
Water|November 2, 2020
Classifying Streamflow Duration: The Scientific Basis and an Operational Framework for Method DevelopmentKen M Fritz, Tracie-Lynn Nadeau, Julia E Kelso, et al.
Peerj|August 4, 2020
The importance of open science for biological assessment of aquatic environmentsMarcus W Beck, Casey O'Hara, Julia S Stewart Lowndes, et al.
The Journal of Experimental Medicine|September 24, 2017
ICAMs support B cell interactions with T follicular helper cells and promote clonal selectionIrina Zaretsky, Ofir Atrakchi, Roei D Mazor, et al.
Neuro-Oncology Advances|July 10, 2020
Dual BRAF/MEK blockade restores CNS responses in BRAF-mutant Erdheim-Chester disease patients following BRAF inhibitor monotherapyRoei D Mazor, Ran Weissman, Judith Luckman, et al.
Environmental Science. Processes & Impacts|June 15, 2017
High throughput in vitro and in vivo screening of inland waters of Southern CaliforniaA C Mehinto, D R VanDervort, W Lao, et al.
Transplantation and Cellular Therapy|April 9, 2025
Omidubicel-onlv Transplantation for Hematologic Malignancies: Results of a Multicenter Expanded Access ProgramMitchell E Horwitz, Gary J Schiller, Stephanie B Tsai, et al.
BMC Medicine|December 2, 2014
Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case seriesRoei D Mazor, Mirra Manevich-Mazor, Anat Kesler, et al.
Kidney International|November 14, 2022
Clinical phenotypes and long-term outcome of kidney involvement in Erdheim-Chester histiocytosisThibaud Chazal, Francesco Pegoraro, Gaia Manari, et al.
Pageof 6